Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
MA06 - PDL1, TMB and DNA Repair
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 12
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 206 AC
-
+
MA06.11 - Distinct Origins of Lymphatic and Brain Metastasis in Lung Cancer
14:40 - 14:45 | Presenter: Tao Jiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA09 - Lung Cancer Surgical and Molecular Pathology
- Type: Mini Oral Abstract Session
- Track: Pathology
- Presentations: 12
- Coordinates: 9/24/2018, 15:15 - 16:45, Room 202 BD
-
+
MA09.11 - Genomic Landscape and its Correlation with TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma
16:25 - 16:30 | Presenter: Tao Jiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
- Presentations: 8
- Coordinates: 9/24/2018, 15:15 - 16:45, Room 107
-
+
OA07.03 - Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC pts with Oligometastatic or Oligoprogressive Liver Metastases
15:35 - 15:45 | Presenter: Tao Jiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.13-26 - First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant Nsclc Patients with Oligoprogressive Disease
16:45 - 18:00 | Presenter: Qinghua Xu
- Abstract
Loading...
-
+
MA11 - Biomarkers of IO Response
- Type: Mini Oral Abstract Session
- Track: Immunooncology
- Presentations: 12
- Coordinates: 9/25/2018, 10:30 - 12:00, Room 203 BD
-
+
MA11.11 - Discrepancy of Tumor Neoantigen Burden Between Primary Lesions and Matched Metastases in Lung Cancer
11:40 - 11:45 | Presenter: Tao Jiang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 12
- Coordinates: 9/25/2018, 13:30 - 15:00, Room 107
-
+
MA15.09 - Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated with First-Line EGFR-TKIs
14:30 - 14:35 | Presenter: Chunxia Su
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA15.10 - Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
14:35 - 14:40 | Presenter: Sha Zhao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 29
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.04-21 - Antibiotics Attenuate the Clinical Benefit of Anti-PD-(L)1 Immunotherapies in Chinese Patients with Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Sha Zhao
- Abstract
Loading...
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 201 BD
-
+
MA26.05 - Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients with Different ALK Fusion-Variants
14:00 - 14:05 | Presenter: Meng Qiao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA27 - Novel Drugs and PDX Models
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 206 BD
-
+
MA27.10 - EGFR-Targeted Therapy Alters the Tumor Microenvironment In EGFR-Driven Lung Tumors: Rationale for Combination Therapies
14:35 - 14:40 | Presenter: Yijun Jia
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
